The effects of L-Dopa on attention in Parkinson's disease and Parkinson's dementia patients

被引:0
|
作者
Molloy, S
McKeith, IG
Burn, D
Wesnes, KA
机构
[1] Newcastle Gen Hosp, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
[2] Cognit Drug Res, Goring On Thames RG8 0EN, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A51 / A51
页数:1
相关论文
共 50 条
  • [21] Hyperhomocysteinemia in L-Dopa Treated Patients with Parkinson's Disease: Potential Implications in Cognitive Dysfunction and Dementia?
    Zoccolella, S.
    Lamberti, S. V.
    Iliceto, G.
    Santamato, A.
    Lamberti, P.
    Logroscino, G.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (28) : 3253 - 3261
  • [22] The evolution of the acute response to L-dopa in Parkinson's disease
    Hughes, AJ
    Lees, AJ
    MOVEMENT DISORDERS, 2002, 17 : S97 - S98
  • [23] L-Dopa plasma levels variability in Parkinson's disease
    Albani, G.
    Cattaldo, S.
    Mauro, A.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S118 - S118
  • [24] Does L-dopa have toxic effects in Parkinson's disease brain?
    Parkkinen, L.
    O'Sullivan, S.
    Holton, J. L.
    Kuoppamaki, M.
    Lees, A.
    Revesz, T.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 : 28 - 28
  • [25] Effect of L-dopa on gastric motility in Parkinson's disease
    Albani, G.
    El Assawy, N.
    Cataldo, S.
    Mauro, A.
    JOURNAL OF NEUROLOGY, 2007, 254 : 64 - 65
  • [26] The effects of early versus late L-DOPA initiation in Parkinson's disease
    Yahalom, G.
    Cohen, O. S.
    Warmann-Alaluf, N.
    Shabat, C.
    Strauss, H.
    Elincx-Benizri, S.
    Israeli-Koren, S.
    Stein, E.
    Hassin-Baer, S.
    MOVEMENT DISORDERS, 2015, 30 : S298 - S298
  • [27] THE L-DOPA RESPONSE IN PATHOLOGICALLY CONFIRMED PARKINSON'S DISEASE
    Pitz, Vanessa
    Malek, Naveed
    Grosset, Katherine A.
    Grosset, Donald G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [28] L-DOPA and cortical associative plasticity in Parkinson's disease
    Suppa, Antonio
    Bologna, Matteo
    Berardelli, Alfredo
    CLINICAL NEUROPHYSIOLOGY, 2013, 124 (04) : 638 - 639
  • [29] Paradoxical response to L-dopa and apomorphine in the Parkinson's disease
    García-Soldevilla, MA
    Puertas, I
    Barcenilla, B
    Sayed, Y
    García-Albea, E
    Jiménez-Jiménez, FJ
    MOVEMENT DISORDERS, 2002, 17 : S96 - S96
  • [30] Parkinson's disease, L-DOPA, and endogenous morphine: A revisit
    Stefano, George B.
    Mantione, Kirk J.
    Kralickova, Milena
    Ptacek, Radek
    Kuzelova, Hana
    Esch, Tobias
    Kream, Richard M.
    MEDICAL SCIENCE MONITOR, 2012, 18 (08): : RA133 - RA137